NEUROBO PHARMACEUTICALS INC's ticker is NRBO and the CUSIP is 64132R107. A total of 31 filers reported holding NEUROBO PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.27 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $1,000 | -66.7% | 3,044 | 0.0% | 0.00% | – |
| Q1 2022 | $3,000 | -25.0% | 3,044 | 0.0% | 0.00% | – |
| Q4 2021 | $4,000 | -63.6% | 3,044 | 0.0% | 0.00% | – |
| Q3 2021 | $11,000 | +10.0% | 3,044 | -0.1% | 0.00% | – |
| Q2 2021 | $10,000 | -23.1% | 3,048 | 0.0% | 0.00% | – |
| Q1 2021 | $13,000 | -18.8% | 3,048 | 0.0% | 0.00% | – |
| Q4 2020 | $16,000 | – | 3,048 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SABBY MANAGEMENT, LLC | 232,547 | $1,872,000 | 0.38% |
| Hayden Royal, LLC | 22,682 | $182,591,000 | 0.10% |
| Exchange Capital Management, Inc. | 11,145 | $90,000 | 0.02% |
| Tower Research Capital LLC (TRC) | 5,117 | $41,000 | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 106,922 | $861,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 2,188 | $18,000 | 0.00% |
| NORTHERN TRUST CORP | 78,159 | $629,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| UBS Group AG | 1,768 | $14,000 | 0.00% |
| Legal & General Group Plc | 697 | $6,000 | 0.00% |